Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


Med Ad News Insider

Archive for the ‘ Social media in pharma ’ Category

A place for your apps

Friday, December 2nd, 2011

Late yesterday, the healthcare communications agency Palio launched PharmApps, a wiki that aggregates pharma and healthcare apps. The wiki gives users the ability to comment, write a review, rate apps, share, and upload new apps. The apps are categorized in order to enable users to sift through this ever-growing resource. ...

FDA and social media guidance

Tuesday, November 8th, 2011

(Editor's note: I asked Arnie Friede, an attorney with expertise in FDA and social media regulatory matters, to offer some of his thoughts about these issues on a regular basis. He has obliged, and we'll be hearing from him again. You can also hear Arnie talk with Pharmalot Editor at ...

Reducing healthcare costs through ‘mHealth?’

Wednesday, November 2nd, 2011

As Bob Allen, the director of mobile and social media at AstraZeneca, told the audience last month during his presentation at the Digital Pharma East conference in Philadelphia, “think Mobile first.” Not surprisingly, going mobile was a big focus of the conference. With 500 million estimated to be using mobile health ...

The CementBloc launches online forum for marketing strategies

Tuesday, November 1st, 2011

Based on the touch of the bed sheets against her skin upon waking at 6:30 a.m,, Mary Johnson, 45, can tell whether it will be a good or bad day. Throughout the day, Ms. Johnson overcomes a number of barriers to routine activities – including using a large key holder ...

Intouch Solutions Expands to East Coast

Monday, September 26th, 2011

[caption id="attachment_845" align="alignleft" width="99" caption="Jack Lipton, senior VP, client services"][/caption] Wendy Blackburn, the executive VP at Intouch Solutions, a pharma marketing agency, says agency officials have “high hopes” for Intouch’s recent expansion into New York City, especially given the agency’s 400 percent growth over the past three years. The new office, located ...

Digital marketing in pharma: more than just an ‘add-on’ to current strategy

Friday, September 16th, 2011

Bonin Bough, global director of digital and social media at PepsiCo and now one of the members of Pozen’s revolutionary Digital Advisory Board (DAB), has heard it often from a variety of people: they have better Internet browser versions at home than they do at work. “That’s crazy,” says Mr. Bough. ...

A new approach to improving adherence and compliance: focus on pharmacists’ perspectives

Friday, September 9th, 2011

When researchers at Industry Standard Research (ISR) Reports decided about six months ago that they wanted to study the topic of adherence and compliance, they stumbled upon a few pieces that sent them in a new direction: pharmacists’ perspectives on the issue. The result is a newly released 144-page report conducted ...

Making the digital connection — with physicians?

Thursday, September 8th, 2011

A recent study has found that when it comes to social media, physicians are logging in – both personally and professionally. That they are digitally connected represents a variety of opportunities for stakeholders, including payers, pharma and med tech companies, and others, to reach physicians and their patients more effectively.

This too shall pass: Pozen’s new board aims to ease digital wariness

Wednesday, September 7th, 2011

It turns out there is a lot the pharmaceutical advertising world can learn from outside the industry. In fact, at a time when many pharma companies are shying away from anything digital, Pozen has embraced the idea. Pozen has formed an unprecedented Digital Advisory Board (DAB) to identify untapped digital strategies ...

Bayer’s Twitter mishap provides lesson in cultural and regulatory differences

Tuesday, August 30th, 2011

When the Prescription Medicines Code of Practice Authority (PMCPA) reprimanded Bayer HealthCare this month for breaching the ABPI Code of Practice in two of the company’s postings on Twitter, the ruling may have exacerbated wariness about social media within the pharmaceutical industry. Industry sources say, though, that drug companies should not ...